Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs

AIM: To quantify the economic burden of early-stage non-small-cell lung cancer (NSCLC) among patients with and without adjuvant therapy. METHODS: All-cause and NSCLC-related healthcare resource utilization and medical costs were assessed among patients with resected stage IB–IIIA NSCLC in the SEER–M...

Descripción completa

Detalles Bibliográficos
Autores principales: Apple, Jon, DerSarkissian, Maral, Shah, Anne, Chang, Rose, Chen, Yan, He, Xuanhao, Chun, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690396/
https://www.ncbi.nlm.nih.gov/pubmed/37655686
http://dx.doi.org/10.57264/cer-2023-0107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690396/
https://www.ncbi.nlm.nih.gov/pubmed/37655686
http://dx.doi.org/10.57264/cer-2023-0107

Ejemplares similares